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Background Little is known about the risk of non-recurrent adverse birth outcomes.
Objectives To evaluate the risk of stillbirth, preterm birth (PTB), and small for gestational age (SGA) as a proxy for fetal growth restriction (FGR) following exposure to one or more of these factors in a previous birth.
Search strategy We searched MEDLINE, EMBASE, Maternity and Infant Care, and Global Health from inception to 30 November 2016.
Selection criteria Studies were included if they investigated the association between stillbirth, PTB, or SGA (as a proxy for FGR) in two subsequent births.
Data collection and analysis Meta-analysis and pooled association presented as odds ratios (ORs) and adjusted odds ratios (aORs).
Main results Of the 3399 studies identified, 17 met the inclusion criteria. A PTB or SGA (as a proxy for FGR) infant increased the risk of subsequent stillbirth ((pooled OR 1.70; 95% confidence interval, 95% CI, 1.34-2.16) and (pooled OR 1.98; 95% CI 1.70-2.31), respectively). A combination of exposures, such as a preterm SGA (as a proxy for FGR) birth, doubled the risk of subsequent stillbirth (pooled OR 4.47; 95% CI 2.58-7.76). The risk of stillbirth also varied with prematurity, increasing three-fold following PTB <34 weeks of gestation (pooled OR 2.98; 95% CI 2.05-4.34) and six-fold following preterm SGA (as a proxy for FGR) <34 weeks of gestation (pooled OR 6.00; 95% CI 3. 43-10.49) . A previous stillbirth increased the risk of PTB (pooled OR 2.82; 95% CI 2.31-3.45), and subsequent SGA (as a proxy for FGR) (pooled OR 1.39; 95% CI 1.10-1.76).
Introduction
Stillbirth, preterm birth (PTB), and small for gestational age (SGA) (as a proxy for fetal growth restriction, FGR) continue to be major public health problems, despite improvements in health care. They are the leading cause of infant morbidity and mortality. [1] [2] [3] Globally, around 2.6 million infants are stillborn each year. 2 It is estimated that almost 15 million infants are born preterm, 4 and at least 32 million infants are born SGA (as a proxy for FGR). 5 Those who survive are at increased risk of longterm developmental and health complications. 6 The recurrence of adverse birth outcomes (stillbirth, PTB, and SGA, as a proxy for FGR) from one pregnancy to the next has been widely acknowledged. [7] [8] [9] [10] A recent meta-analysis of 16 studies investigating the recurrence of stillbirth reported a four-fold increase in the relative risk. 7 Women with PTB in the first birth have a 2.5-to 10.6-fold increased risk of recurrence, 11, 12 and the risk of recurrence is nearly 14 times greater for PTB <34 weeks of gestation. 13 Women who experienced SGA (and its proxy FGR) in the previous pregnancy have at least an eight-fold increased risk of recurrence. 8 Traditionally, stillbirth, PTB, and SGA (as a proxy for FGR) have been viewed as separate entities; however, they can be observed together, and their aetiology can be partially attributed to common antecedents (i.e. placental insufficiency).
14,15 SGA (as a proxy for FGR) is a common cause of preventable stillbirth, accounting for up to 50% of cases, 16, 17 and many preterm infants are growth restricted. 18 The association between these adverse birth outcomes implies that they might inform the risk of non-recurrent adverse outcomes in subsequent pregnancies; however, relatively little attention has been directed to the investigation of potential adverse outcomes of a subsequent pregnancy, apart from the risk of recurrence. 7 Hence, each of these adverse birth outcomes could be markers of a predisposition to subsequent other adverse outcomes as well as to recurrence. 8, 10 Identifying at-risk pregnancies may provide an opportunity to target interventions to prevent adverse outcomes in multiparous pregnancies.
The aim of this study was to undertake a systematic review and meta-analysis of current evidence to determine the non-recurrent risk of stillbirth, PTB, and SGA (as a proxy for FGR) following exposure to these birth outcomes in a previous pregnancy.
Methods

Search strategy
We conducted a systematic review and meta-analysis, adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). 19 We searched MEDLINE, EMBASE, Maternity and Infant Care, and Global Health through Ovid from inception to 30 November 2016, using consistent search terms (Appendix S1).
Eligibility criteria
Eligible studies included peer-reviewed articles that reported the non-recurrent risk of adverse birth outcomes following exposure to one or more of these in the previous pregnancy. Adverse birth outcomes included: stillbirth, commonly defined as fetal death from 20 weeks of gestation; PTB with birth <37 completed weeks of gestation; and SGA (as a proxy for FGR), defined as infant birthweight for gestational age and sex below the tenth percentile. We used the term 'non-recurrent risk' for crossoutcome measures, such as preterm birth in the first pregnancy and stillbirth in the next pregnancy, as opposed to 'recurrent risk' for a recurrence of each condition. Studies were restricted to singleton births of gestations >20 weeks. Two authors (EM and AR) independently screened the titles and abstracts of the identified articles before performing a full-text review.
Quality assessment
The quality of the selected studies was independently assessed (EM and AR) using the Newcastle-Ottawa Quality Assessment Scale. 20 Cohort studies were assessed according to: (1) selection (representative exposed and non-exposed cohorts, reliable ascertainment of exposure, and outcome set at the start of the study); (2) comparability (risk factors accounted for); and (3) outcome (appropriate assessment, with sufficient and adequate follow up). Studies could score up to nine, with nine representing the highest quality.
Data extraction
For each study, data were extracted on sample size, study design, data source, location, study period, exposure, outcome measure of interest, adjustment or matching variables, effect size, and variability of the effect (EM).
Statistical analysis
We estimated pooled effect sizes by applying randomeffects meta-analysis with the inverse variance method, which accounts for both heterogeneity within and between studies and appropriately weights the estimates by the inverse of the standard error of the log odds ratio. 21, 22 We calculated pooled odds ratios (ORs) from all studies that provided adjusted odds ratios or hazard ratios. 23 We estimated pooled effect sizes for unadjusted estimates (informative for risk assessment) as well as adjusted estimates (informative for causal assessment) to verify findings. The unadjusted effect sizes were calculated using the raw counts of births. Data were analysed in STATA 12.1 (STATA, College Station, Texas, USA).
Heterogeneity and publication bias
We reported the I 2 statistic as a measure of heterogeneity between studies. 24 We also conducted sensitivity analyses to investigate potential sources of heterogeneity in our data by restricting analyses to studies with ≥8 points on the Newcastle-Ottawa Quality Assessment, and from high-income settings. Egger's weighted regression test was used to assess publication bias. 25 
Results
Study selection
We identified 960 MEDLINE, 1683 EMBASE, 550 Infant Care, and 206 Global Health citations (Figure 1 ). After the removal of duplicates, there were 1891 citations, and the further exclusion of 1752 citations based on the title and abstract left 139 articles for full-text review. Additionally, we searched the reference lists of these 139 articles and conducted an Internet search and identified three additional citations. Of these, 17 studies fulfilled the eligibility criteria (Table S1 ), whereas 125 studies were excluded (Table S2 ).
Study characteristics
The 17 studies included in the systematic review consisted of 14 retrospective and three prospective cohort studies (Table S1 ). Studies were published between 1994 and 2013, with combined data spanning 1967 to 2013. Three of the studies were from North America, 13, 26, 27 eight were from Europe, [28] [29] [30] [31] [32] [33] [34] [35] two were from Australia, 36,37 one was from Asia, 38 one was from Latin America, 39 one was from the Middle East, 40 and one was from Africa, Asia, and Latin America combined. 41 Eleven studies investigated stillbirth from a range of gestational ages, including ≥20 weeks (n = 8), 13, 26, 27, 29, 34, [36] [37] [38] ≥22 weeks (n = 3), 30, 33, 41 or later (≥23, ≥24, or ≥28 weeks). 28, 31, 35, 40 One study did not describe the gestational week from which the stillbirth was recorded. 32 Although PTB <37 weeks of gestation was used by most studies (n = 13), 13, [26] [27] [28] [29] 31, 32, [35] [36] [37] [38] [39] 41 seven investigated PTBs <34 weeks of gestation (n = 2), 13, 29 <33 weeks of gestation (n = 2), 27, 30 and <32 weeks of gestation (n = 3). 35, 36, 38 Five studies classified subgroups of gestational age: moderate PTB (32-36, 33-36 and 34-36 weeks of gestation); 26, 30, [33] [34] [35] very PTB (28-32 and 29-33 weeks of gestation); 26, 33, 34 and extremely PTB (20-27, 20-28, and 22-27 weeks of gestation). 26, 33, 34 For the five studies that did not report odds ratios for PTB, we used the counts for subcategories of PTB to estimate odds ratios. 26, 30, [33] [34] [35] Seven studies defined SGA (as a proxy for FGR) as birthweights below the tenth percentile, 26, 27, 31, 33, 37, 40, 41 whereas three others used birthweights that were two standard deviations (2SDs) below the mean. 32, 34, 35 With the exception of two studies, 30 ,40 all studies controlled for one or more covariates (Tables S3-S5) , either by adjustment, clustering, or matching, using a range of sociodemographic, pregnancy complications, and other risk factors. The most commonly adjusted variables were: maternal age, marital status, and mother's level of education (among sociodemographic factors); gestational diabetes, pre-eclampsia, and hypertensive diseases (among pregnancy complications); and inter-pregnancy interval, mother's smoking status, body mass index (BMI), parity, and year of subsequent delivery.
Effects of previous birth outcomes on risk of stillbirth
Results from individual studies, including frequency, and unadjusted and adjusted odds ratios for previous adverse birth outcomes followed by stillbirth (Table S6) , preterm stillbirth (Tables S7-S8) , SGA (as a proxy for FGR) stillbirth (Table S9) , PTB (Tables S10-S14), preterm SGA (as a proxy for FGR) birth (Table S15) , or SGA (as a proxy for FGR) birth (Table S16) , in a subsequent pregnancy are presented in the supplementary material.
In the unadjusted analysis, the pooled odds ratio of stillbirth following PTB was 1.70 (95% CI 1.34-2.16). The association varied by prematurity ( preterm (OR 3.99; 95% CI 2.53-6.30), and six times higher for SGA (as a proxy for FGR) birth <34 weeks of gestation (pooled OR 6.00; 95% CI 3.43-10.49) ( Table 1 ). The odds of stillbirth were greater if the previous preterm SGA (as a proxy for FGR) birth was more severe, with a birthweight <2SD (OR 5.08; 95% CI 3.58-7.20), than if the previous preterm SGA (as a proxy for FGR) birthweight was below the tenth percentile (pooled OR 4.28; 95% CI 1.85-9.90). The odds of stillbirth were also greater for a previous preterm SGA (as a proxy for FGR) birth <34 weeks of gestation and with a birthweight <2SD (OR 8.05; 95% CI 4.72-13.71) than for a previous preterm SGA (as a proxy for FGR) birth <34 weeks of gestation with a birthweight below the tenth percentile (OR 4.55; 95% CI 2.77-7.48). The unadjusted pooled odds ratio of preterm stillbirth after previous PTB was 2.70 (95% CI 2.41-3.03), and the pooled odds ratio more than doubled for PTB <34 weeks of gestation (OR 4.94; 95% CI 4.06-6.01) (data not shown). Similarly, the unadjusted odds ratio for SGA (as a proxy for FGR) stillbirth after PTB was 2.91 (95% CI 2.05-4.13), and the effect increased nine-fold after PTB <34 weeks of gestation (OR 8.90; 95% CI 5.08-15.62) (Table S9) . A previous SGA (as a proxy for FGR) birth resulted in a greater effect, with the odds of SGA (as a proxy for FGR) stillbirth of 12.63 (95% CI 7.67-20.79), and the odds doubled following SGA (as a proxy for FGR) birth <34 weeks of gestation (OR 24.95; 95% CI 12.73-48.91) ( Table S9 ).
Effects of previous birth outcomes on risk of preterm birth
In the unadjusted analysis, the pooled odds of PTB after stillbirth was OR 2.82 (95% CI 2.31-3.45), and the effect varied with the extent of prematurity from a pooled OR 2.42 (95% CI 1.80-3.26) for risk of moderate PTB to OR 9.88 (95% CI 6.29-15.50) for risk of extreme PTB (Table 2) . In unadjusted analysis, the odds ratio of PTB after SGA (as a proxy for FGR) birth was 2.7 (95% CI 2.0-3.7) ( Table S10 ).
Effects of previous birth outcomes on risk of SGA (as a proxy for FGR)
The pooled unadjusted odds ratio of SGA (as a proxy for FGR) birth alone after PTB was 1.66 (95% CI 1.53-1.81), and this effect moderately varied with the extent of prematurity from OR 1.60 (95% CI 1.46-1.75) after moderate PTB to OR 2.14 (95% CI 1.41-3.26) after extreme PTB ( Table S16 ). The pooled odds ratio of SGA (as a proxy for FGR) after stillbirth was 1.39 (95% CI 1.10-1.76), and the effect slightly increased for the odds of preterm SGA (as a proxy for FGR) birth OR 1.74 (95% CI 1.14-2.65) ( Table 2 ).
Adjusted analyses
Effects on risk of stillbirth were only slightly attenuated and were largely consistent with unadjusted analyses. The pooled adjusted odds ratios of stillbirth were 2.05 (95% CI 1.18-3.55) after PTB, 1.85 (95% CI 1.42-2.40) after SGA (as a proxy for FGR), and 4.51 (95% CI 2.94-6.91) after preterm SGA (as a proxy for FGR) <34 weeks of gestation ( Table 1) . The effects of previous stillbirth on risk of adverse pregnancy outcomes were generally attenuated, yet were largely consistent after adjustment. The adjusted effects of previous stillbirth were pooled OR 2.27 (95% CI 1.90-2.72) for the risk of PTB, OR 1.90 (95% CI 1.16-3.10) for the risk of moderate PTB, and OR 4.20 (95% CI 1.78-9.90) for the risk of extreme PTB ( Table 2 ). The odds ratio of SGA (as a proxy for FGR) was also similar after adjustment.
Heterogeneity and publication bias
The I 2 statistics varied from 0 to 88% for unadjusted pooled estimates, and from 0 to 72% for adjusted pooled estimates (Tables 1 and 2 ). Heterogeneity attenuated slightly after adjustment for the odds of stillbirth after PTB or SGA (as a proxy for FGR), but remained moderate (≥70%; Table 1 ). Heterogeneity for the odds of PTB after stillbirth was sensitive to the inclusion of specific studies: dropping one study (study ID = 1) increased the heterogeneity from 0 to 48% for the unadjusted pooled odds ratio of PTB after stillbirth.
An evaluation of Egger's regression intercepts demonstrated that there was insufficient statistical evidence of publication bias for studies investigating the risk of stillbirth after PTB (n = 6; Egger's regression intercept, -1.32; 95% CI -6.25, -3.61; P = 0.499), and the risk of PTB after stillbirth (n = 6; Egger's regression intercept, À2.70; 95% CI À7.64, À2.23; P = 0.203).
Quality and sensitivity analyses
Of the 17 studies included, the quality ranged from 5 to 9 (median 9). Fourteen out of 17 (82%) studies were fit for the purpose of our study, with quality scores of ≥8 (Table S1 ). A sensitivity analysis of the 14 studies that scored ≥8 showed little change in the risk estimates, as did a sensitivity analysis of 13 studies from high-income settings (USA, Finland, Denmark, Norway, Sweden, Scotland, Italy, Australia, and Israel; results not shown).
Discussion
Main findings
We found consistent evidence for a moderate increase in the likelihood of stillbirth, PTB, or SGA (as a proxy for FGR) in women who previously experienced a single adverse birth outcome, which doubled with increasing severity of the exposure, and increased two-to three-fold in some cases when two exposures were combined. Although the recurrence of stillbirth, PTB, and SGA (as a proxy for FGR) is widely acknowledged, [7] [8] [9] [10] cross-outcome risks between successive pregnancies are much less well understood. To our knowledge, this is the first study to synthesise the current body of knowledge on risk of stillbirth, PTB, and SGA (as a proxy for FGR) to ascertain the effect of exposure to these in the previous pregnancy. 
Strengths and limitations
A major strength of this review was that we employed a comprehensive, well-described and replicable search strategy. Two independent reviewers examined the titles and abstract and conducted the full-text review. The studies included large populations of women from high-to lowincome countries, and from diverse settings. We were able to evaluate the effect of multiple exposures and outcomes. In addition to unadjusted pooled estimates, we also calculated pooled adjusted effect sizes and confirmed that the effects were largely consistent before and after adjustment. We also performed two sets of sensitivity analyses, within higher quality studies or high-income countries, and both made little change to the pooled effect sizes, thus confirming the robustness of our findings. There was insufficient statistical evidence of publication bias of the reviewed studies based on Egger's test. We were able to calculate heterogeneity in only a few instances, as estimating heterogeneity for fewer than three studies is not meaningful. As the observed heterogeneity in the pooled estimates between studies ranged from none (for stillbirth as an exposure) to substantial, the findings need to be interpreted with caution. Only 17 studies were included in this review, thus demonstrating a lack of research investigating adverse birth outcomes followed by non-recurrent adverse outcomes in the next pregnancy. Most studies investigated the risk of stillbirth after PTB or the risk of PTB after stillbirth, with only a few studies focusing on the relative risk of SGA (as a proxy for FGR), and with fewer still investigating the interaction between different adverse pregnancy outcomes. There were minor differences in the definition of stillbirth and PTB categories, which may have either overestimated or underestimated the relative risk. Of the few studies investigating SGA (as a proxy for FGR), most used the standard definition of birthweights below the tenth percentile. 3, 8, 9, 11, 13, 14, 17 There were not enough studies using the more severe cut-off point of SGA (as a proxy for FGR) <2SD to be included separately in any of the pooled analyses; however, for comparison, we have reported odds separately for the two cut-off points in addition to their combined odds. SGA is only a proxy for FGR. Ten studies did not differentiate between spontaneous and medically indicated PTB, [4] [5] [6] [9] [10] [11] 13, 14, 16, 17 with only three studies focusing on spontaneous PTB, 3, 12, 15 and with one study focusing on medically indicated PTB, 1 and another focusing on PTB related to pre-eclampsia. 2 One study reported the odds of PTB following stillbirth for all PTB, and then separately for spontaneous PTB, with slightly higher odds for spontaneous PTB. 36 Another limitation was that the cause of stillbirth was unknown for most studies, and no study stratified the risk by the cause of stillbirth. Stillbirth is the end point of multiple processes, including placental dysfunction. There are a number of stillbirth classification schemes in use that assign cause of death and/or factors contributing to stillbirth. [41] [42] [43] Common causes or factors associated with stillbirth include congenital malformations, infection, hypoxia, fetal growth disorders, and PTB, and by identifying the cause of stillbirth, targeting interventions could be applied. 44 
Interpretation
Our finding that women who experienced PTB or SGA (as a proxy for FGR) have at least a 1.7-fold increased risk of subsequent stillbirth suggests that adverse (non-recurrent) birth outcomes are equally (if not more) important risk factors for stillbirth as other behavioural or demographic factors, such as smoking during pregnancy (pooled OR 1.47), primaparity (pooled adjusted OR 1.42), 45 advanced maternal age (>35 years; pooled adjusted OR 1.65), or maternal obesity (BMI > 30kg/m 2 , pooled adjusted OR 1.63). 45 The effect was increased by prematurity, with a previous PTB <34 weeks of gestation associated with a three-fold greater risk of stillbirth. This risk is comparable with the risk of stillbirth associated with the mother's medical conditions, such as pre-existing hypertension (adjusted OR 2.58) or pre-existing diabetes (adjusted OR 2.90), 45 and may have been attributable to some of these conditions. Similarly, the effect of SGA (as a proxy for FGR) increased with severity, and was greater for a birthweight cut-off point of 2SD than for the tenth percentile.
A more pronounced four-fold increase in the risk of stillbirth was observed when previous adverse birth outcomes were combined, which is comparable with the risk reported for recurrent stillbirth (OR 4.77, or 3.38 after adjustment); 7 however, the risk of stillbirth was higher still when the combination of adverse birth outcomes involved increased prematurity. SGA (as a proxy for FGR) birth <34 weeks of gestation was one of the strongest risk factors for stillbirth (pooled OR 6.00, or 4.51 after adjustment), with SGA (as a proxy for FGR) birth <34 weeks of gestation with a birthweight <2SD being even more at risk (OR 8.05, or 5.00 after adjustment). The greatest risk observed was the effect of combined preterm SGA (as a proxy for FGR) birth on SGA (as a proxy for FGR) stillbirth however, which increased the odds by 15, but this was based on a single study of more than 400 000 women. 35 Thus, confirmation is required. Nevertheless, these results highlight that the likelihood of adverse birth outcomes following a previous event is strong, and that these are not random events and are at increased risk and require routine monitoring in subsequent pregnancies.
Stillbirth as an exposure in the previous pregnancy was associated with a nearly three-fold increase in the odds of PTB, and a ten-fold increase in risk for extremely PTB; however, this was based on just a single study and more research is needed for confirmation. 26 Similarly, only one study considered SGA (as a proxy for FGR) as an exposure for subsequent PTB, and the findings were similar to a previous exposure to stillbirth. 32 Exposure to stillbirth in the previous pregnancy led to a modest increased risk in the odds of SGA (as a proxy for FGR), which stands in stark contrast to the six-fold increase reported by the Royal College of Obstetricians and Gynaecologists (RCOG) clinical guideline no. 31 (accessed 28 February 2017) . 46 This guideline references an Australian case-control study of infants born to women in a socio-economically disadvantaged region, with no indication of the number of stillbirths or whether the stillbirths referred to previous pregnancy or any prior history of stillbirth. 47 More research is required to provide conclusive evidence regarding the risk of SGA (as a proxy for FGR) after previous stillbirth, as the three studies that were included in our review reported odds ranging from 1.00 to 1.51, all considerably less than that cited in the RCOG guideline. 46 Our results highlight the importance of identifying the underlying pathophysiology that may be driving the increased risk of adverse birth outcomes, particularly as congenital anomalies, maternal conditions such as preeclampsia, and potential placental dysfunction are some of the leading causes of stillbirth, and are also strongly associated with PTB and SGA (as a proxy for FGR).
14,15 Targeted interventions to mitigate this underlying mechanism in multiparous pregnancies could significantly improve perinatal health.
Most of the increases in the odds of adverse birth outcomes that we identified were greater than OR 2.0. An OR of 2.0 is used by RCOG to identify women at risk of SGA (as a proxy for FGR), who require extra monitoring with serial ultrasounds and assessment with umbilical artery Doppler from 26 to 28 weeks of gestation. 46 Identifying women at high risk of adverse birth outcomes may enable interventions to reduce the risk in subsequent births. 48 This may include aspirin to reduce the risk of pre-eclampsia, SGA (as a proxy for FGR), PTB, and stillbirth. 49 In addition, cervical ultrasound surveillance to predict PTB may enable intervention with progesterone or cerclage, 50 or ultrasound surveillance of fetal growth to detect SGA (as a proxy for FGR) and enable intervention by planned birth. 46 Induction of labour, which has also been shown to be associated with a reduction in perinatal deaths compared with conservative management post-dates, may also be considered, 51 especially where the background risk of stillbirth is high. 44 
Conclusion
Stillbirth, PTB, and SGA (as a proxy for FGR) are strongly interrelated, and each condition predisposes women to the other outcomes in the next pregnancy. It is important for health providers to be aware of the risks involved for women with a history of adverse birth outcomes and to offer appropriate antenatal care.
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